New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 13, 2012
09:20 EDTTRIBTrinity Biotech Plc target raised to $14.50 from $13 at Roth Capital
Roth Capital increased its target on Trinity after the company reported higher than expected EPS. The firm maintains a Buy rating.
News For TRIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 30, 2015
08:29 EDTTRIBTrinity Biotech appoints Eric Brouwer, PhD, as Chief Scientific Officer
Trinity Biotech (TRIB) announced the appointment of Eric Brouwer, PhD, as Chief Scientific Officer, or CSO, and vice president Cardiac. Previously, Dr Brouwer led product development at Abbott (ABT) Point-of-Care. Dr Jim Walsh, who previously held the positions of both Business Development Director and CSO, will now focus on business development with an emphasis on the identification and execution of suitable acquisition targets.
08:27 EDTTRIBTrinity Biotech reports Q1 EPS 17c, consensus 17c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use